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Breast cancer represents the most incident cancer case in women (29%), with high mortality rate. Bone 
metastases occurs in 20-50% cases and, despite advances in breast cancer research, the interactions 
between tumor cells and the bone metastatic microenvironment are still poorly understood. In vitro 3D 
models gained great interest in cancer research thanks to the reproducibility, the 3D spatial cues and 
associated low costs, compared to in vivo and 2D in vitro models. 
In this study, we investigated the interactions between breast cancer stem cells and the bone 
microenvironment by using a poly-ether-urethane foam (PU) as 3D in vitro model. 
The PU foam used as an in vitro model was synthesised by reacting an optimised poly-ether-polyol 
mixture with isocyanate MDI prepolymer, using Fe-AcetylAcetonate as catalyst and water as foaming 
agent1. The measured PU foam open porosity (> 70%) proved to be suitable to mimic the trabecular 
bone structure. PU foam showed good and stable mechanical properties under cyclic compression, 
even if lower than human trabecular bone. The in vitro bone metastasis model was produced by seeding 
on the PU foam patient-derived human adipose derived stem cells (ADSCs) and by differentiating them 
into osteoblasts for four weeks; subsequently, breast cancer derived stem cells (MCFS) were co-
cultured on the PU foam with differentiated ADSCs for three weeks. Successful ADSCs attachment and 
elongation was shown by hematoxylin-eosin staining. Moreover, efficient osteoblastic differentiation was 
proved both by inorganic matrix deposition evidenced by alizarin red staining and RT-PCR (Fig1); a 
significant increase of osteopontin levels was shown in cells differentiated on PU foam compared to 
those differentiated on control tissue culture plastics (TCPS), suggesting that the PU foam can recreate 
a more physiological-like and biomimetic microenvironment for osteoblastic differentiation than TCPS 
surface. 
 
Tumor cells agglomerates were identified on PU foam co-cultured with ADSC/MCFS by e-cadherin 
staining. SEM/EDX images showed a homogeneous and well-distributed deposition of Ca and P sub-
micrometric particles on PU foam seeded only with ADSCs (Fig2a, Ca in red), confirming osteoblastic 
differentiation. On the contrary, when breast cancer derived stem cells were co-cultured with 
differentiated ADSCs, tumor cells agglomerates were observed (Fig2b) and a qualitative desorption of 
Ca and P particles in some areas of the PU foam pore walls was detected. The PU foam demonstrated 
to be a suitable model for reproducing a bone biomimetic microenvironment in vitro, allowing for the co-
culturing of differentiated ADSCs and MCFS, and for the investigation of their interaction. 
1 Bertoldi S et al. J Mater Sci Mater Med. 2010;21(3):1005-11. 
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